Literature DB >> 485455

[Hyperprolactinemia and sterility].

H K Rjosk, R Fahlbusch, K von Werder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485455

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


× No keyword cloud information.
  46 in total

1.  Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.

Authors:  A M Mroueh; T M Siler-Khodr
Journal:  J Clin Endocrinol Metab       Date:  1976-12       Impact factor: 5.958

Review 2.  [Hyperprolactinemia. Pathophysiology, clinical significance, therapy].

Authors:  K Von Werder; R Fahlbusch; H K Rjosk
Journal:  Internist (Berl)       Date:  1977-10       Impact factor: 0.743

3.  Visual disturbance in pregnancy after induction of ovulation.

Authors:  G I Swyer; V Little; B J Harries
Journal:  Br Med J       Date:  1971-10-09

4.  Human prolactin: isolation and some properties.

Authors:  U J Lewis; R N Singh; B K Seavey
Journal:  Biochem Biophys Res Commun       Date:  1971-09       Impact factor: 3.575

5.  Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.

Authors:  S W Lamberts; H J Seldenrath; H G Kwa; J C Birkenhäger
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

6.  Prolactin secretion in sixty-five patients with galactorrhea.

Authors:  G Tolis; M Somma; J Van Campenhout; H Friesen
Journal:  Am J Obstet Gynecol       Date:  1974-01-01       Impact factor: 8.661

7.  Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.

Authors:  G M Besser; L Parke; C R Edwards; I A Forsyth; A S McNeilly
Journal:  Br Med J       Date:  1972-09-16

8.  [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].

Authors:  H K Rjosk; K Werder; R Fahlbusch
Journal:  Geburtshilfe Frauenheilkd       Date:  1976-07       Impact factor: 2.915

9.  Treatment of patients with prolactinomas.

Authors:  K v Werder; R Fahlbusch; R Landgraf; C R Pickardt; H K Rjosk; P C Scriba
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

10.  Pregnancy, prolactin, and pituitary tumours.

Authors:  D F Child; H Gordon; K Mashiter; G F Joplin
Journal:  Br Med J       Date:  1975-10-11
View more
  2 in total

Review 1.  Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

2.  Present status of neurosurgery in the treatment of prolactinomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.